Abstract
One of the hallmarks of modern science is technically controlled experimentation. In this paper, we underline how technical developments over the last 150 years have repeatedly created new horizons in amyloid research. The main focus is on chemical and biophysical analyses of amyloid fibrils in vivo and in vitro. Investigations into mechanistic aspects of fibril formation and possible links with pathogenesis are also discussed.
Keywords: Amyloid, history, milestones, experimental method, experimental technique
Protein & Peptide Letters
Title: A Short Historical Survey of Developments in Amyloid Research
Volume: 13 Issue: 3
Author(s): Mireille Dumoulin and Reto Bader
Affiliation:
Keywords: Amyloid, history, milestones, experimental method, experimental technique
Abstract: One of the hallmarks of modern science is technically controlled experimentation. In this paper, we underline how technical developments over the last 150 years have repeatedly created new horizons in amyloid research. The main focus is on chemical and biophysical analyses of amyloid fibrils in vivo and in vitro. Investigations into mechanistic aspects of fibril formation and possible links with pathogenesis are also discussed.
Export Options
About this article
Cite this article as:
Dumoulin Mireille and Bader Reto, A Short Historical Survey of Developments in Amyloid Research, Protein & Peptide Letters 2006; 13 (3) . https://dx.doi.org/10.2174/092986606775338434
DOI https://dx.doi.org/10.2174/092986606775338434 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fetuin-A: A Multifunctional Protein
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Endothelial (Dys)Function in Lone Atrial Fibrillation
Current Pharmaceutical Design Hepatocyte Growth Factor Attenuates the Development of TGF-β1- Induced EndMT through Down-regulating the Notch Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria
Current Clinical Pharmacology Gut Microbiota as a Therapeutic Target for Metabolic Disorders
Current Medicinal Chemistry Glycolytic Inhibition and Antidiabetic Activity on Synthesized Flavanone Scaffolds with Computer Aided Drug Designing Tools
Letters in Drug Design & Discovery Application of in vivo Magnetic Resonance Imaging for Islet Transplantation
Micro and Nanosystems Taste Transductions in Taste Receptor Cells: Basic Tastes and Moreover
Current Pharmaceutical Design Immunosuppression and Post-transplant Hyperglycemia
Current Diabetes Reviews The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Safety of Inhaled Fluticasone Propionate Therapy for Pediatric Asthma - A Systematic Review
Current Drug Safety Nanoparticles: Functionalization and Multifunctional Applications in Biomedical Sciences
Current Medicinal Chemistry Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines
Current Pharmacogenomics and Personalized Medicine Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation
Current Gene Therapy The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases
Current Genomics Advanced Glycation: Implications in Tissue Damage and Disease
Protein & Peptide Letters Human Ghrelin: A Gastric Hormone with Cardiovascular Properties
Current Pharmaceutical Design Single Stem Cell Positioning on Polylysine and Fibronectin Microarrays
Micro and Nanosystems Role of Statins on the Prevention of Coronary Spasm
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued)